Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENOXAPARIN Cause Clostridium difficile infection? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Clostridium difficile infection have been filed in association with ENOXAPARIN (Enoxaparin Sodium). This represents 0.1% of all adverse event reports for ENOXAPARIN.

13
Reports of Clostridium difficile infection with ENOXAPARIN
0.1%
of all ENOXAPARIN reports
3
Deaths
10
Hospitalizations

How Dangerous Is Clostridium difficile infection From ENOXAPARIN?

Of the 13 reports, 3 (23.1%) resulted in death, 10 (76.9%) required hospitalization, and 4 (30.8%) were considered life-threatening.

Is Clostridium difficile infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENOXAPARIN. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does ENOXAPARIN Cause?

Off label use (1,707) Exposure during pregnancy (1,215) Haemorrhage (1,059) Foetal exposure during pregnancy (918) Anaemia (914) Thrombocytopenia (834) Dyspnoea (822) Maternal exposure during pregnancy (818) Drug ineffective (769) Nausea (708)

What Other Drugs Cause Clostridium difficile infection?

ADALIMUMAB (1,502) INFLIXIMAB (1,419) VEDOLIZUMAB (1,130) LENALIDOMIDE (814) VANCOMYCIN (743) METRONIDAZOLE (619) PREDNISONE (618) METHOTREXATE (588) RITUXIMAB (532) CIPROFLOXACIN (508)

Which ENOXAPARIN Alternatives Have Lower Clostridium difficile infection Risk?

ENOXAPARIN vs ENOXAPARIN - WINTHROP ENOXAPARIN vs ENSIFENTRINE ENOXAPARIN vs ENTACAPONE ENOXAPARIN vs ENTECAVIR ENOXAPARIN vs ENTINOSTAT

Related Pages

ENOXAPARIN Full Profile All Clostridium difficile infection Reports All Drugs Causing Clostridium difficile infection ENOXAPARIN Demographics